Skip to main content
Home
Main navigation
  • About Us
  • Services
  • News & Insights
  • Careers
  • The GR Company
  • EN/한국어
  • Contact Us
  • English
  • 한국어

Drug pricing to be more transparent: Gov’t continues systematic reform push

We at GR Korea are pleased to share important and noteworthy news in the healthcare sector of this month. We would also like to take this opportunity to thank you for your continued interest and support.Please refer to the attached document for detai...
Mar, 2024
Insights

GR Korea - AMCHAM AI Accelerate Summit 2024

Juyun Moon, Executive Director of The GR Company and Head of Operations in Korea, was invited to speak at the AMCHAM AI Accelerate Summit 2024. She presented about the Korean government’s AI policy priorities, aimed at promoting the AI industry, as w...
Mar, 2024
Events
Blue House

Parties' division, alliance, and candidate nomination

The 22nd General Election in Korea is just over a month away. Korea’s two major parties – the People Power Party (PPP) and the Democratic Party (DP) – are accelerating their candidate nomination and pledge development efforts. As of 6 March, ahead of...
Mar, 2024
Insights

Kicking off the 22nd General Election

With 50 days remaining, Korea's 22nd General Election is fast approaching.This election has the potential to significantly shift the current Korean political landscape. Accordingly, major political parties, as well as newly formed ones, have been gea...
Mar, 2024
Insights

Crisis in healthcare: Government moves to raise med school quota amid protests

Following January's newsletter, GR Korea is delighted to present important updates from the healthcare sector for this month. We also welcome your active feedback and appreciate your continued interest.Please refer to the attached document for detail...
Feb, 2024
Insights
Healthcare

The NA audit for biopharma: Key issues & what to expect

Happy new year! We are pleased to share the first 2024 edition of our healthcare newsletter. We at GR Korea have prepared this newsletter to provide our clients and partners in the healthcare sector with noteworthy developments. We hope to bring you key updates on a regular basis this year to help you stay informed about the latest developments pertaining to the biotech and pharmaceutical industries.
Jan, 2024
Insights
GR Korea Expands Its Leadership Team with Top Executive Hire

GR Korea Expands Its Leadership Team with Top Executive Hire

- Immediate past President of the European Chamber of Commerce, Christoph Heider, Joins GR Korea as Associate Director -Seoul – 18 October 2023 – GR Korea Ltd., the leading and largest government relations and public affairs consultancy in Korea, tod...
Oct, 2023
News
Healthcare

Healthcare - News & Update

Here are healthcare highlights from the National Assembly audit and recent policy discussions within the government. Feel free to contact our expert consultants at GR Korea should you have any inquiries.  
Nov, 2022
Insights
100_days_of_president_yoon_suk-yeol.jpg

100 Days of President Yoon Suk-yeol

Since his inauguration on 10 May, Yoon Suk-yeol has spent his first 100 days pursuing an expansive agenda that includes promoting public-private cooperation and improving a wide range of regulations. GR Korea's First 100 Days tracks the 20th presiden...
Aug, 2022
Insights
chongho_lee_0.jpg

My Internship at GR Group (3)

The GR Group offers an excellent internship program for talented university students and graduates, many of whom are seeking to pursue a career in government relations.We sat down with Chongho Lee  to ask about his experience as an intern. 1. Why did...
Jul, 2022
News

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››

CONTACT US

By sending, I agree to the Privacy Policy.
Footer
  • About
  • Services
  • News & Insights
  • Careers
  • Contact
Social Profile
  • LinkedIn
Sitewide
  • GR Japan
  • GR Taiwan
  • The GR Company
  • EN/JP

© 2025 GR Korea

Menu Term
  • Privacy policy